LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,977 | -18.0% | 16,493 | +72.4% | 0.00% | – |
| Q2 2023 | $21,911 | -77.9% | 9,568 | -55.5% | 0.00% | – |
| Q2 2021 | $99,000 | -13.2% | 21,505 | +10.7% | 0.00% | – |
| Q1 2021 | $114,000 | +7.5% | 19,422 | -37.3% | 0.00% | – |
| Q4 2020 | $106,000 | -95.7% | 30,970 | -98.2% | 0.00% | -100.0% |
| Q3 2020 | $2,462,000 | -27.8% | 1,709,776 | 0.0% | 0.01% | -25.0% |
| Q2 2020 | $3,411,000 | +143.6% | 1,709,776 | +138.2% | 0.01% | +100.0% |
| Q1 2020 | $1,400,000 | +200.4% | 717,707 | +538.5% | 0.00% | +300.0% |
| Q4 2019 | $466,000 | +46500.0% | 112,397 | +158205.6% | 0.00% | – |
| Q3 2019 | $1,000 | -98.4% | 71 | -99.3% | 0.00% | – |
| Q2 2019 | $62,000 | -11.4% | 9,862 | -21.8% | 0.00% | – |
| Q1 2019 | $70,000 | +1066.7% | 12,611 | +1317.0% | 0.00% | – |
| Q4 2018 | $6,000 | -92.3% | 890 | -79.3% | 0.00% | – |
| Q3 2016 | $78,000 | – | 4,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $14,779,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $243,430,000 | 5.23% |
| BVF INC/IL | 10,963,000 | $37,493,000 | 1.48% |
| Integral Health Asset Management, LLC | 300,000 | $1,026,000 | 0.30% |
| NEA Management Company, LLC | 2,382,286 | $8,147,000 | 0.22% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $122,000 | 0.13% |
| PINNACLE ASSOCIATES LTD | 1,852,382 | $6,335,000 | 0.13% |
| XTX MARKETS LLC | 13,242 | $45,000 | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 828,192 | $2,832,000 | 0.06% |
| WINTON GROUP Ltd | 192,890 | $660,000 | 0.05% |